These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23593810)

  • 1. [The value of drug level testing in the assessment of chronic pain syndromes].
    Wolff D
    Versicherungsmedizin; 2013 Mar; 65(1):24-5. PubMed ID: 23593810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug testing and adherence monitoring in pain management: Oral fluid testing.
    Moore C
    J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.
    Hale ME; Zimmerman TR; Ma Y; Malamut R
    J Opioid Manag; 2015; 11(5):425-34. PubMed ID: 26535970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A leader in the field...
    DeVito RA
    J Opioid Manag; 2015; 11(1):6. PubMed ID: 25881374
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoassay in healthcare testing applications.
    DePriest AZ; Black DL; Robert TA
    J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonopioids Prove Noninferior for Chronic Pain: Results of SPACE Trial.
    Kolcun JPG; Brusko GD; Wang MY
    World Neurosurg; 2018 May; 113():267-268. PubMed ID: 29555608
    [No Abstract]   [Full Text] [Related]  

  • 9. Using urine drug testing to support healthy boundaries in clinical care.
    Heit HA; Gourlay DL
    J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is my patient drug-seeking or in need of pain relief?
    Arnstein P
    Nursing; 2010 May; 40(5):60-1. PubMed ID: 20386408
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment.
    Yang H; Feng Y; Xu XS
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):229-48. PubMed ID: 24428494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidisciplinary care pathway to manage osteoarticular chronic pain. ASON proposal].
    Mammucari M; Gigliotti S; Pucino A; Capezza M; Santè G
    Recenti Prog Med; 2015 Mar; 106(3):118-24. PubMed ID: 25805222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sore thing.
    Nature; 2015 Feb; 518(7540):456. PubMed ID: 25719627
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrathecal drug administration in chronic pain syndromes.
    Ver Donck A; Vranken JH; Puylaert M; Hayek S; Mekhail N; Van Zundert J
    Pain Pract; 2014 Jun; 14(5):461-76. PubMed ID: 24118774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The controversy over urine drug testing in pain management patient monitoring.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):320-1. PubMed ID: 24303832
    [No Abstract]   [Full Text] [Related]  

  • 19. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.
    McMillin GA; Slawson MH; Marin SJ; Johnson-Davis KL
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):322-39. PubMed ID: 24147959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.